Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Non-cash Items (2017 - 2022)

Arcus Biosciences has reported Non-cash Items over the past 6 years, most recently at $6.7 million for Q4 2022.

  • Quarterly results put Non-cash Items at $6.7 million for Q4 2022, down 97.36% from a year ago — trailing twelve months through Dec 2022 was $6.7 million (down 97.36% YoY), and the annual figure for FY2022 was $6.7 million, down 97.36%.
  • Non-cash Items for Q4 2022 was $6.7 million at Arcus Biosciences, down from $253.6 million in the prior quarter.
  • Over the last five years, Non-cash Items for RCUS hit a ceiling of $253.6 million in Q4 2021 and a floor of $238721.0 in Q4 2018.
  • Median Non-cash Items over the past 5 years was $6.7 million (2022), compared with a mean of $57.4 million.
  • Biggest five-year swings in Non-cash Items: skyrocketed 9827.91% in 2019 and later tumbled 97.36% in 2022.
  • Arcus Biosciences' Non-cash Items stood at $238721.0 in 2018, then skyrocketed by 9827.91% to $23.7 million in 2019, then plummeted by 88.21% to $2.8 million in 2020, then soared by 8980.4% to $253.6 million in 2021, then tumbled by 97.36% to $6.7 million in 2022.
  • The last three reported values for Non-cash Items were $6.7 million (Q4 2022), $253.6 million (Q4 2021), and $2.8 million (Q4 2020) per Business Quant data.